Fludeoxyglucose (18F) Injection; Cracket vial
Last updated
Summary
Product
Fludeoxyglucose (18F) Injection
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Audience
Healthcare
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| BC Cancer, Part of the provincial Health Services Authority | Fludeoxyglucose (18F) Injection | DIN 02433230 | Solution | Fludeoxyglucose 18F 0.5 GBq/vial | FDG20260627A |
Issue
Fludeoxyglucose (18F) vial containing 24.80 mL (30.23 GBq of the product) used to administered the drug to the patients was found to be broken at the bottom.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs - Radiopharmaceuticals
Companies
BC Cancer, Part of the provincial Health Services Authority
600 West 10th Avenue
Vancouver, British Columbia V5Z 4E6 Canada
Published by
Health Canada
Audience
Healthcare
Recall class
Type III
Identification number
RA-82272
Get notified
Receive emails about new and updated recall and safety alerts.